Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical calendula versus essential fatty acids for prevention and treatment of radiodermatitis in head and neck cancer radiotherapy
RBR-237v4bPhase 3Recruiting
- Sponsor
- Hospital Erasto Gaertner
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of calendula in radiodermatitis, sponsored by Hospital Erasto Gaertner. Started Oct 2011; status: recruiting.
02
Drugs
calendula
03
Conditions
radiodermatitis
Beyond the preview
Go deeper on RBR-237v4b.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-237v4b.